170 related articles for article (PubMed ID: 22077405)
1. Detection of the tumour suppressor gene TP53 and expression of p53, Bcl-2 and p63 proteins in canine transmissible venereal tumour.
Stockmann D; Ferrari HF; Andrade AL; Cardoso TC; Luvizotto MC
Vet Comp Oncol; 2011 Dec; 9(4):251-9. PubMed ID: 22077405
[TBL] [Abstract][Full Text] [Related]
2. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
3. Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis.
Setthawongsin C; Techangamsuwan S; Tangkawattana S; Rungsipipat A
J Vet Med Sci; 2016 Aug; 78(7):1167-73. PubMed ID: 27075116
[TBL] [Abstract][Full Text] [Related]
4. The T963C mutation of TP53 gene does not participate in the clonal origin of canine TVT.
Vázquez-Mota N; Simón-Martínez J; Córdova-Alarcon E; Lagunes L; Fajardo R
Vet Res Commun; 2008 Feb; 32(2):187-91. PubMed ID: 17668284
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of canine LINE-1 elements and p53 gene in canine transmissible venereal tumor.
Choi YK; Kim CJ
J Vet Sci; 2002 Dec; 3(4):285-92. PubMed ID: 12825561
[TBL] [Abstract][Full Text] [Related]
7. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.
Sánchez-Servín A; Martínez S; Córdova-Alarcon E; Fajardo R
J Vet Sci; 2009 Dec; 10(4):353-5. PubMed ID: 19934603
[TBL] [Abstract][Full Text] [Related]
8. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
[TBL] [Abstract][Full Text] [Related]
9. Identification of mitochondrial DNA transfer in canine transmissible venereal tumours obtained from dogs in Mexico.
Bautista-Gómez L; Martínez-Castañeda S
Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Sep; 28(5):645-649. PubMed ID: 27159723
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial capture by a transmissible cancer.
Rebbeck CA; Leroi AM; Burt A
Science; 2011 Jan; 331(6015):303. PubMed ID: 21252340
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological study of canine transmissible venereal tumour in leishmaniotic dogs.
Marino G; Gaglio G; Zanghì A
J Small Anim Pract; 2012 Jun; 53(6):323-7. PubMed ID: 22489831
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
[TBL] [Abstract][Full Text] [Related]
13. A multicancer-like syndrome in a dog characterized by p53 and cell cycle-checkpoint kinase 2 (CHK2) mutations and sirtuin gene (SIRT1) down-regulation.
Marfe G; De Martino L; Tafani M; Irno-Consalvo M; Pasolini MP; Navas L; Papparella S; Gambacurta A; Paciello O
Res Vet Sci; 2012 Aug; 93(1):240-5. PubMed ID: 21890154
[TBL] [Abstract][Full Text] [Related]
14. Canine transmissible venereal tumour: a review.
Ganguly B; Das U; Das AK
Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response.
Flórez MM; Fêo HB; da Silva GN; Yamatogi RS; Aguiar AJ; Araújo JP; Rocha NS
Vet Comp Oncol; 2017 Sep; 15(3):793-807. PubMed ID: 26879698
[TBL] [Abstract][Full Text] [Related]
16. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
[TBL] [Abstract][Full Text] [Related]
17. Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model.
Chiang HC; Liao AT; Jan TR; Wang YS; Lei HJ; Tsai MH; Chen MF; Lee CY; Lin YC; Chu RM; Lin CS
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):207-16. PubMed ID: 23237908
[TBL] [Abstract][Full Text] [Related]
18. Vaginal canine transmissible venereal tumour associated with intra-tumoural Leishmania spp. amastigotes in an asymptomatic female dog.
Kegler K; Habierski A; Hahn K; Amarilla SP; Seehusen F; Baumgärtner W
J Comp Pathol; 2013; 149(2-3):156-61. PubMed ID: 23348016
[TBL] [Abstract][Full Text] [Related]
19. Use of a murine xenograft model for canine transmissible venereal tumor.
Harmelin A; Pinthus JH; Katzir N; Kapon A; Volcani Y; Amariglio EN; Rehavi G
Am J Vet Res; 2001 Jun; 62(6):907-11. PubMed ID: 11400849
[TBL] [Abstract][Full Text] [Related]
20. Canine transmissible venereal tumor (TVT): a review.
Vermooten MI
J S Afr Vet Assoc; 1987 Sep; 58(3):147-50. PubMed ID: 3334057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
